Hyphenated technique reveals valuable information about plasma proteins
Researchers show how an AF4-ICP-MS system is able to obtain valuable information on the multi-element speciation and absolute molecular mass of human plasma proteins such as Albumin and Transferrin.
Postnova Analytics reports on exciting advances in the analysis of plasma proteins using a hyphenated system that couples asymmetric flow Field-Flow Fractionation (AF4) and inductively coupled plasma-mass spectrometry (ICP-MS). In a new application study researchers show how an AF4-ICP-MS system is able to obtain valuable information on the multi-element speciation and absolute molecular mass of human plasma proteins such as Albumin and Transferrin.
Human Serum Albumin (HSA) and Transferrin are the two main plasma proteins that are known to bind and transfer metal ions in biological fluids. Metal-protein complexes are involved in many health studies such as metal-based drugs for cancer or diabetes treatments. Asymmetric flow field-flow fractionation (AF4) is very similar to liquid chromatography, and has been successfully applied to protein fractionation in several biological applications. However unlike liquid chromatography for which fractionation occurs by interaction with a stationery phase, AF4’s lack of stationery phase offers improved recovery for a range of species from complex biological matrices. Further the AF4 technique has been able to achieve this (in some cases) using non-denaturing carriers, which offers significant benefits for the separation of unstable protein metal complexes.
In the application study, a Postnova AF2000 Multiflow Mid Temperature Field-Flow Fractionation system coupled with an Agilent 7700 ICP-MS system was used to separate a mixture of Human Serum Albumin binding 63Cu and Transferrin binding 56Fe metal ions. The AF2000 system separated the proteins by size and the ICP-MS system detected the metal ions to obtain metal distributions of the protein mixture. The researchers demonstrate that AF4-ICP-MS is an excellent tool for the non-denaturing and element-selective detection of plasma proteins.
The demonstrated benefits of the AF4-ICP-MS technique show particular promise for demanding applications in which the two plasma proteins under study act as binders of the same element (e.g., vanadium in Diabetes studies). Other applications under investigation by Postnova, using the AF4-ICP-MS technique, include patient physiology studies involving identification of metal uptake in plasma; investigation and optimization of therapeutic protein and antibody production; detection of protein contamination, and quality control of therapeutic protein and antibodies.
Related News
-
News Patients vs Pharma – who will the Inflation Reduction Act affect the most?
The Inflation Reduction Act brought in by the Biden administration in 2022 aims to give better and more equitable access to healthcare in the USA. However, pharma companies are now concerned about the other potential costs of such legislation. -
News CPHI Podcast Series: What does the changing US Pharma market mean for industry and patients alike?
In this week's episode of the CPHI Podcast Series Lucy Chard, Digital Editor for CPHI Online is joined by James Manser to discuss the political and market changes in the US pharma field. -
News CPHI Barcelona Annual Report illuminates industry trends for 2024
The CPHI Annual Survey comes into it’s 7th year to report on the predicted trends for 2024. Over 250 pharma executives were asked 35 questions, with their answers informing the industry landscape for the next year, spanning all major pharma marke... -
News Which 10 drugs are open to price negotiation with Medicare in the USA?
The Centres for Medicare & Medicaid Services, under the Biden administration in the USA, has released a list of the 10 drugs that will be open to price negotiations as part of the new legislation under the Inflation Reduction Act (IRA). -
News EU Medical Devices Regulation causes unintended disappearances of medical devices for children, doctors state
Doctor groups and associations have appealed to the EU to correct the EU Medical Devices Regulation law that may cause unintended shortages of essential drug and medical devices for children and rare disease patients. -
News 10 Major Drug Approvals So Far in 2023
Last year, 37 novel drugs were approved by the FDA, this was a high number for such a category, and covered many fields including oncology, demonstrating how promising further research is, and how it is only continuing to build. To date, there are alre... -
News Detecting Alzheimer's disease with a simple lateral flow test
A novel rapid diagnostic test for early-stage Alzheimer's disease has been developed using a biomarker binder from Aptamer Group along with technology from Neuro-Bio, the neurodegenerative disease experts. -
News CPHI Podcast Series: outsourcing and manufacturing trends
Listen to the CPHI Podcast Series this June to hear Gil Roth of the PBOA speak with Digital Editor Lucy Chard about the biggest trends and topics to watch in pharma outsourcing and manufacturing at the minute.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance